[P25-10] P25-10: Oncologic drugs (2)

[P25-10-1] Retrospective investigation of concomitant medications as potential risk factors for sever neutropenia in cancer patients treated with carboplatin and paclitaxel combination therapy

Yurie Katsube¹, Daiki Hira², Masayuki Tsujimoto³, Hiroyoshi Koide⁴, Tetsuya Minegaki⁵, Yoshito Ikeda⁶, Shin-Ya Morita⁷, Kohshi Nishiguchi⁸, Tomohiro Terada⁹ (1.Kyoto Pharmaceutical University, 2.Shiga University of Medical Science Hospital, 3.Kyoto Pharmaceutical University, 4.Kyoto Pharmaceutical University, 5.Kyoto Pharmaceutical University, 6.Shiga University of Medical Science Hospital, 7.Shiga University of Medical Science Hospital, 8.Kyoto Pharmaceutical University, 9.Shiga University of Medical Science Hospital)

Keywords:Neutropenia, Paclitaxel, Carboplatin, Candesartan, Magnesium oxide